(GMRE) Global Medical REIT - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US37954A2042

GMRE: Healthcare Facilities, Medical Offices, Physician Practices

Global Medical REIT Inc., listed as GMRE on the New York Stock Exchange, operates as a net-lease medical office real estate investment trust. This structure enables the company to focus on acquiring, owning, and managing a portfolio of healthcare facilities. These facilities are then leased to a diverse range of tenants, including physician groups and both regional and national healthcare systems, providing them with the space they need to deliver medical services.

The company's investment strategy is centered around the healthcare sector, which is known for its resilience and steady demand. By concentrating on medical office buildings and other healthcare-related properties, Global Medical REIT aims to generate stable cash flows through long-term leases. This approach allows the company to provide a predictable income stream to its shareholders. With a specific focus on the healthcare industry, Global Medical REIT is well-positioned to capitalize on trends such as the aging population and the increasing need for healthcare services.

From a financial and regulatory standpoint, Global Medical REIT Inc. is classified under the GICS Sub Industry of Health Care REITs, reflecting its specialized focus within the real estate investment trust sector. The company's common stock is traded under the ticker symbol GMRE, and its ISIN code is US37954A2042, which is a unique identifier used for trading and clearing purposes. For more detailed information about the company's activities, mission, and performance, investors and interested parties can visit the company's official website at https://www.globalmedicalreit.com.

As a real estate investment trust, Global Medical REIT is required to distribute a significant portion of its taxable income to shareholders in the form of dividends, which can make it an attractive option for income-seeking investors. The company's portfolio of healthcare facilities, leased to a variety of healthcare providers, contributes to a diversified revenue stream. This diversification, combined with the essential nature of healthcare services, can help mitigate some of the risks associated with real estate investments, making Global Medical REIT a consideration for those looking to invest in the healthcare sector through a real estate investment trust.

Additional Sources for GMRE Stock

GMRE Stock Overview

Market Cap in USD 546m
Sector Real Estate
Industry REIT - Healthcare Facilities
GiC Sub-Industry Health Care REITs
IPO / Inception 2016-06-29

GMRE Stock Ratings

Growth 5y -25.9%
Fundamental 4.12%
Dividend 77.1%
Rel. Strength Industry -19.2
Analysts 4.1/5
Fair Price Momentum 7.74 USD
Fair Price DCF 21.28 USD

GMRE Dividends

Dividend Yield 12m 10.62%
Yield on Cost 5y 8.02%
Annual Growth 5y 0.98%
Payout Consistency 90.5%

GMRE Growth Ratios

Growth Correlation 3m -72.9%
Growth Correlation 12m 10.9%
Growth Correlation 5y -33.5%
CAGR 5y -5.44%
CAGR/Mean DD 5y -0.20
Sharpe Ratio 12m -0.42
Alpha -25.18
Beta 0.67
Volatility 25.06%
Current Volume 253.9k
Average Volume 20d 454.2k
What is the price of GMRE stocks?
As of February 09, 2025, the stock is trading at USD 7.91 with a total of 253,870 shares traded.
Over the past week, the price has changed by +0.89%, over one month by +2.73%, over three months by -9.53% and over the past year by -7.81%.
Is Global Medical REIT a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Global Medical REIT is currently (February 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 4.12 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GMRE as of February 2025 is 7.74. This means that GMRE is currently overvalued and has a potential downside of -2.15%.
Is GMRE a buy, sell or hold?
Global Medical REIT has received a consensus analysts rating of 4.10. Therefor, it is recommend to buy GMRE.
  • Strong Buy: 5
  • Buy: 1
  • Hold: 4
  • Sell: 0
  • Strong Sell: 0
What are the forecast for GMRE stock price target?
According to ValueRays Forecast Model, GMRE Global Medical REIT will be worth about 8.6 in February 2026. The stock is currently trading at 7.91. This means that the stock has a potential upside of +8.98%.
Issuer Forecast Upside
Wallstreet Target Price 10.8 36.8%
Analysts Target Price 10.8 37%
ValueRay Target Price 8.6 9%